Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea.


Journal

Epidemiology and health
ISSN: 2092-7193
Titre abrégé: Epidemiol Health
Pays: Korea (South)
ID NLM: 101519472

Informations de publication

Date de publication:
2021
Historique:
received: 08 09 2020
accepted: 10 03 2021
entrez: 27 4 2021
pubmed: 28 4 2021
medline: 19 5 2021
Statut: ppublish

Résumé

Recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 and 11 and is potentially preventable through vaccination. This study estimated the incidence of juvenile-onset RRP before the implementation of the national HPV vaccination program in Korea. We conducted a cohort study using claims data provided by a mandatory insurance program to estimate the incidence of RRP and associated healthcare use. Patients with juvenile RRP were defined as those aged ≤12 years with ≥2 admissions or ≥2 outpatient visits during which they received the International Classification of Diseases, 10th revision code for benign neoplasms of the larynx (D14.1). During 2002-2014, 123 children (74 boys and 49 girls) were diagnosed with RRP. The patients had a mean of 6.5 person-years of follow-up. The incidence was estimated at 0.30/100,000 person-years. The median age at diagnosis was 4.0 years (mean, 4.3). Thirty-six (29.3%) patients underwent surgery, including 23 patients (18.7%) who underwent 2 or more surgical procedures. Severe disease, measured by more frequent surgical procedures and shorter time intervals between consecutive operations, was associated with a younger age at diagnosis. The estimated incidence of juvenile-onset RRP in Korea was similar to that reported in other countries. The RRP burden should continue to be monitored using National Health Insurance Service claims data.

Identifiants

pubmed: 33906285
pii: epih.e2021019
doi: 10.4178/epih.e2021019
pmc: PMC8189843
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2021019

Subventions

Organisme : National Cancer Center
ID : NCC-2010303
Pays : Republic of Korea
Organisme : National Cancer Center
ID : NCC-1710141
Pays : Republic of Korea

Références

Sex Transm Dis. 2014 May;41(5):300-5
pubmed: 24722383
PLoS One. 2014 Jun 11;9(6):e99114
pubmed: 24918765
J Formos Med Assoc. 2006 Jun;105(6):508-11
pubmed: 16801040
Int J Pediatr Otorhinolaryngol. 2014 Dec;78(12):2113-5
pubmed: 25300480
Int J Pediatr Otorhinolaryngol. 2014 Feb;78(2):186-97
pubmed: 24367938
Respir Med. 2017 May;126:116-121
pubmed: 28427542
Clin Otolaryngol. 2018 Apr;43(2):533-537
pubmed: 29054106
Obstet Gynecol. 2003 Apr;101(4):645-52
pubmed: 12681865
Ther Clin Risk Manag. 2015 May 05;11:731-8
pubmed: 25999724
J Bras Pneumol. 2008 Dec;34(12):1084-9
pubmed: 19180346
Int J Epidemiol. 2017 Jun 1;46(3):799-800
pubmed: 27794523
Otolaryngol Clin North Am. 2012 Jun;45(3):671-94, viii-ix
pubmed: 22588043
Diagn Interv Radiol. 2009 Jun;15(2):93-5
pubmed: 19517378
Laryngoscope. 2012 Jul;122(7):1595-9
pubmed: 22565595
Clin Infect Dis. 2000 Jul;31(1):107-9
pubmed: 10913405
Case Rep Oncol. 2011 Mar 23;4(1):162-71
pubmed: 21526134
PLoS One. 2019 Jun 13;14(6):e0216697
pubmed: 31194767
Acta Otorhinolaryngol Ital. 2014 Dec;34(6):375-81
pubmed: 25762828
Arch Otolaryngol Head Neck Surg. 2003 Sep;129(9):976-82
pubmed: 12975271
Clin Otolaryngol. 2017 Feb;42(1):86-91
pubmed: 27208548
Laryngoscope. 2010 Jun;120(6):1233-45
pubmed: 20513045
J Infect Dis. 2018 Jan 4;217(2):208-212
pubmed: 29136168
Vaccine. 2012 Nov 20;30 Suppl 5:F34-54
pubmed: 23199965
Laryngoscope. 2016 Dec;126(12):2827-2832
pubmed: 27074766

Auteurs

Jin-Kyoung Oh (JK)

Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.
Cancer Risk Appraisal and Prevention Branch, National Cancer Center, Goyang, Korea.

Hwa Young Choi (HY)

Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.
Department of Health Sciences, Hanyang University, Seoul, Korea.

Minji Han (M)

Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.

Yuh-Seog Jung (YS)

Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.
Department of Otorhinolaryngology, Center for Thyroid Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

Sang Joon Lee (SJ)

Department of Otorhinolaryngology-Head and Neck Surgery, Dankook University College of Medicine, Cheonan, Korea.

Moran Ki (M)

Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH